Major bleeding risk assessment in atrial fibrillation patients taking vitamin K antagonists

Major bleeding risk assessment in atrial fibrillation patients taking vitamin K antagonists

Show other versions (1)

Background. The use of risk scores for the assessment of major bleeding and stroke in patients with atrial fibrillation (AF) helps evaluate the risks and benefits of oral anticoagulation therapy. The aim of this study was to describe the percentage of  patients receiving anticoagulants for non-valvu...

Full description

Bibliographic Details
Main Authors: Fernando Pivatto Júnior, André Luís Ferreira da Silva, Indira Valente Bezerra, Leonardo Martins Pires, Luís Carlos Amon, Marina Bergamini Blaya, Rafael Selbach Scheffel
Format: Article
Language:English
Published: Hospital de Clinicas de Porto Alegre ; Universidade Federal do Rio Grande do Sul (UFRGS) 2015-07-01
Series:Clinical and Biomedical Research
Subjects:
hemorrhage
stroke
atrial fibrillation
warfarin
phenprocoumon
Online Access:http://seer.ufrgs.br/index.php/hcpa/article/view/54273

Internet

http://seer.ufrgs.br/index.php/hcpa/article/view/54273

Similar Items